CLINICAL_TRIALS
trial_result
· 2009-08-07
Clinical Trial Update: Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults [Phase 1]
Summary
Phase 1 study evaluating the safety and immune response of the rDEN4delta30-4995 dengue vaccine in healthy adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue | Phase 1 | Status: COMPLETED